Pursuant to Reg 30 read with Schedule III Part A Para A of SEBI LODR as amended from time to time and in accordance with SEBI Circular HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated 30th January 2026, we hereby enclose the copies of Advertisement published for Equity Shareholders of the Company regarding the special window for transfer and dematerialisation of physical securities.
With reference to the Communication Module Queries raised by BSE regarding Shareholding Pattern filed under Regulation 31 of SEBI (LODR), we hereby submit a comprehensive clarification. The discrepancies highlighted across the previous quarters (June 2024 till December 2025) have been clarified in the letter along with a summary table explaining all details in one sheet. Please take this into record and close the status of discrepancies in communication module.
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI Listing Obligation and Disclosure Requirements Regulation, 2015 we hereby inform you that Mr Nagayasamy Rajkumar DIN 00617000 has completed his 5 year tenure as Independent Director of the Company. Consequently he ceases to be an Independent Director of the Company with effect from the close of business hours on June 8, 2026. The detailed disclosure as required under Regulation 30 of SEBI LODR Regulation read with SEBI circulars is enclosed herewith as Annexure A. We request you to kindly take the above information on your record.
1. Name of shareholder : Sathyanath Pai B Folio No. 00011595; Original cert no.17175; Duplicate cert. no. 44883 ; Distinctive No. From 3005701 To 3005800; No. of shares : 100; Duplicate share cert. issued on 28.05.2026; Cameo (RTA) letter received by company on 5.06,2026. ******* 2. Name of shareholder : Shantilal Padmashi Shah (existing name) Shantilal Padamshi Shah (new name). Folio No. 00018370 ; Original cert.no. 5007; Duplicate cert. no. 44884 ; Distinctive No. From 1788901 To 1789000; No. of shares : 100 ; Duplicate share cert. issued on 03.06.2026: Cameo (RTA) letter received by company on 5.06.2026.
In continuation to the Letter submitted by Chennai Meenakshi Multispeciality Hospital Limited bearing reference No. CMMH/BSEE/2026-27/06 dated April 21, 2026. We would like to inform you that pursuant to Regulation 15(2) of SEBI (LODR) Regulations 2015, the compliance with the Corporate Governance provisions as specified in Reg 17, 17A, 18, 19, 20, 21, 22, 23,24, 24A,25,26,27 and clauses (b) to (i) of sub-regulations (2) of Regulation 46 and para C,D and E of Schedule V shall not apply, in respect of our company as the paid up equity share capital of does not exeed Rupees ten crores and net worth does not exceed rupees twenty five crores, as on the last day of the previous financial year i.e., 31st March, 2026.
Pursuant to Regulation 47 and other applicable provisions of SEBI (LODR) Regulations 2015, please find enclosed herewith copies of the newspaper advertisement published by the Company regarding the Audited financial results for Quarter & financial year ended 31st March, 2026. The audited financial results were considered, approved and taken on record by the Board of Directors of the Company at its meeting held on 25th May, 2026. The advertisement published on 26th May, 2026 in Financial Express-English and Makkal Kural -Tamil. The newspaper clipping are also being made available on the website of the Company at www.cmmh.in.
The Board approved the audited financial results for the quarter and financial year ended 31st March 2026. No dividend was recommended.
This is to intimate that the Board of Directors of the Company at its meeting held on Monday, May 25, 2026 at the registered office of the Company have inter alia approved the Audited Financial Results for the quarter and financial year ended 31st March, 2026. The Board of Directors have not recommended any Dividend for the year 2025-26. The approved Audited Financial Results along with audit report, Cash Flow Statement for the year ended 31st March, 2026 and declaration on the report of auditors with unmodified opinion are enclosed with this letter. Further, we would like to inform that the financial results will be published in the newspapers pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The financial results are also available on the Company’s website – www.cmmh.in. The meeting commenced at 12:00 Hours and concluded at 15:00 Hours.
This is to intimate that the Board of Directors of the Company at its meeting held on Monday, May 25, 2026 at the registered office of the Company have inter alia approved the Audited Financial Results for the quarter and financial year ended 31st March, 2026. The Board of Directors have not recommended any Dividend for the year 2025-26. The approved Audited Financial Results along with audit report, Cash Flow Statement for the year ended 31st March, 2026 and declaration on the report of auditors with unmodified opinion are enclosed with this letter. Further, we would like to inform that the financial results will be published in the newspapers pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The financial results are also available on the Company’s website – www.cmmh.in. The meeting commenced at 12:00 Hours and concluded at 15:00 Hours.
Pursuant to the provisions of Regulation 30 of SEBI (LODR) Regulations, 2015, further to our earlier intimation dated 19th May 2026 regarding the completion of term of Mr. Krishnamoorthi Meyyanathan (DIN: 07845698) as an Independent Director of the Company, we wish to inform you that the Board of Directors of the Company, vide Circular Resolution passed on May 22, 2026, has approved the reconstitution of Audit Committee, Nomination & Remuneration Committee, Stakeholders Relationship Committee as per enclosed attachment.
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 6.54 | 7.10 | 7.71 | 9.55 | 8.75 | 8.07 | 8.83 | 9.17 | 8.65 | 9.47 | 9.11 | 9.81 |
| YOY Revenue Growth % | 2.73% | -0.04% | 1.12% | 28.56% | 33.73% | 13.7% | 14.46% | -3.99% | -1.12% | 17.25% | 3.2% | 7.01% |
| Other Income | 0.10 | 0.04 | 0.15 | 0.18 | 0.08 | 0.08 | 0.26 | 0.42 | 0.27 | 0.34 | 0.27 | 0.24 |
| Total Income | 6.65 | 7.14 | 7.87 | 9.73 | 8.83 | 8.16 | 9.09 | 9.59 | 8.92 | 9.81 | 9.38 | 10.05 |
| Total Expenses + | 6.63 | 7.08 | 7.97 | 9.59 | 9.24 | 8.85 | 9.75 | 9.27 | 9.67 | 9.68 | 9.93 | 10.05 |
| Cost of Materials Consumed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Employee Benefit Expense | 2.37 | 2.41 | 2.66 | 2.36 | 2.33 | 2.35 | 2.60 | 2.36 | 2.42 | 2.34 | 2.63 | 2.33 |
| Other Expenses | 2.27 | 2.23 | 3.06 | 5.06 | 4.84 | 4.59 | 4.81 | 4.74 | 5.05 | 5.06 | 4.91 | 5.10 |
| Operating Profit | -0.09 | 0.02 | -0.26 | -0.04 | -0.49 | -0.77 | -0.92 | -0.10 | -1.03 | -0.21 | -0.82 | -0.24 |
| OPM % | -1.4% | 0.3% | -3.4% | -0.4% | -5.6% | -9.5% | -10.4% | -1.1% | -11.9% | -2.2% | -9% | -2.5% |
| Profit Before Tax + | 0.02 | 0.06 | -0.11 | 0.14 | -0.41 | -0.69 | -0.65 | 0.32 | -0.76 | 0.13 | -0.55 | 0.00 |
| Tax Expense | 0.00 | 0.02 | -0.07 | 0.58 | -0.02 | -0.01 | -0.02 | 0.01 | -0.01 | -0.02 | -0.01 | 0.02 |
| Tax % | 0% | 26% | - | 427.6% | - | - | - | 1.7% | - | -16.5% | - | - |
| Profit After Tax | 0.02 | 0.04 | -0.04 | -0.44 | -0.38 | -0.67 | -0.63 | 0.31 | -0.74 | 0.15 | -0.54 | -0.02 |
| EPS (Basic) | 0.02 | 0.06 | -0.05 | -0.59 | -0.51 | -0.90 | -0.84 | 0.42 | -0.99 | 0.20 | -0.72 | -0.03 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Revenue from Operations | 37.04 | 34.82 | 38.20 | 28.44 | 31.31 | 19.41 |
| YOY Revenue Growth % | 6.38% | -8.86% | 34.34% | -9.17% | 61.3% | - |
| Other Income | 1.12 | 0.85 | 0.47 | 0.48 | 0.47 | 0.59 |
| Total Income | 38.16 | 35.67 | 38.68 | 28.92 | 31.78 | 20.00 |
| Total Expenses + | 39.30 | 37.10 | 38.57 | 27.64 | 27.80 | 21.25 |
| Employee Benefit Expense | 9.72 | 9.64 | 9.80 | 9.22 | 8.27 | 6.92 |
| Other Expenses | 20.08 | 18.98 | 19.91 | 9.43 | 10.41 | 7.25 |
| Operating Profit | -2.26 | -2.28 | -0.37 | 0.80 | 3.51 | -1.84 |
| OPM % | -6.1% | -6.6% | -1% | 2.8% | 11.2% | -9.5% |
| Profit Before Exceptional | -1.15 | -1.43 | 0.10 | 1.28 | 3.98 | -1.25 |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.04 |
| Profit Before Tax + | -1.15 | -1.43 | 0.10 | 1.28 | 3.99 | -1.21 |
| Tax Expense | -0.03 | -0.05 | 0.53 | 0.39 | 0.00 | 0.00 |
| Tax % | - | - | 511.8% | 30.5% | 0% | - |
| Profit After Tax | -1.12 | -1.37 | -0.43 | 0.89 | 3.99 | -1.21 |
| EPS (Basic) | -1.50 | -1.84 | -0.57 | 1.19 | 5.32 | -1.67 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Non-Current Assets + | 13.02 | 16.02 | 15.91 | 14.19 | 14.33 | 13.24 |
| Property, Plant & Equipment | 12.77 | 13.76 | 14.66 | 13.94 | 14.08 | 12.87 |
| Capital Work in Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 |
| Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Assets + | 8.22 | 6.49 | 6.90 | 8.30 | 7.06 | 5.96 |
| Inventories | 0.42 | 0.43 | 0.40 | 0.43 | 0.40 | 0.58 |
| Trade Receivables | 0.90 | 0.80 | 0.64 | 1.18 | 0.92 | 0.79 |
| Cash and Cash Equivalents | 0.64 | 2.65 | 2.79 | 4.53 | 3.24 | 3.10 |
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| LIABILITIES & EQUITY | ||||||
| Total Equity | -3.08 | -1.89 | -0.33 | 0.12 | -0.78 | -4.77 |
| Equity Share Capital | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 |
| Other Equity | -10.54 | -9.36 | -7.80 | -7.35 | -8.25 | -12.24 |
| Non-Current Liabilities | 12.09 | 12.18 | 12.46 | 11.56 | 11.44 | 12.15 |
| Current Liabilities | 12.23 | 12.22 | 10.68 | 10.81 | 10.73 | 11.82 |
| Total Liabilities | 24.32 | 24.39 | 23.14 | 22.37 | 22.16 | 23.97 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Cash from Operating Activities | 0.37 | 2.17 | 2.09 | 2.95 | 3.97 | 1.18 |
| Cash from Investing Activities | -1.62 | -0.75 | -1.86 | -0.91 | -2.21 | -0.14 |
| Cash from Financing Activities | -0.74 | -1.56 | 0.03 | -0.75 | -1.62 | 1.14 |
| Net Increase/Decrease in Cash | -2.00 | -0.14 | 0.26 | 1.29 | 0.14 | 2.18 |